Sign in
4

Changes in Ownership

NeuroPace Inc Filed Acc 0001209191-21-028324

Chief Executive Officer acquired 15,385 shares (grant or award)

  • Chief Executive Officer acquired 7,562 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Favet Michael Chief Executive Officer 2021-04-26 Conversion +7,562 7,562 I
Favet Michael Chief Executive Officer 2021-04-26 Grant or award +15,385 $0.03 $462 22,947 I
Derivatives
Favet Michael Chief Executive Officer 2021-04-26 Conversion · Series A' Preferred Stock −343 0 I
Favet Michael Chief Executive Officer 2021-04-26 Conversion · Series B' Preferred Stock −7,219 0 I
Loading xslF345X03/doc4.xml…